Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Berge

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 28, 2003
[Cloudberry: an important source of ellagic acid, an anti-oxidant]Barbara Thiem, Viktor Berge
European Urology|December 21, 2006
Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waitingViktor Berge, Trevor Thompson, Donald Blackman
Scandinavian Journal of Urology and Nephrology|May 1, 2007
Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waitingViktor Berge, Trevor Thompson, Donald Blackman
Scandinavian Journal of Urology and Nephrology|March 31, 2010
A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early resultsViktor Berge, Eduard Baco, Steinar Johan Karlsen
British Journal of Cancer|November 23, 2021
Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patientsManuel Ramirez-Garrastacho, Viktor Berge, Aija Linē, et al.
Neurourology and Urodynamics|April 12, 2002
Comparative study of pressure-flow parametersLars M Eri, Nicolai Wessel, Ole Tysland, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2016
Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validationLing Wang, Tore Skotland, Viktor Berge, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 21, 2011
Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancerViktor Berge, Eduard Baco, Alv A Dahl, et al.
European Urology Open Science|August 2, 2021
Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy RegimensKirsti Aas, Viktor Berge, Tor Åge Myklebust, et al.
Molecular Cancer|May 10, 2011
Regulation of PBX3 expression by androgen and Let-7d in prostate cancerHåkon Ramberg, Ayham Alshbib, Viktor Berge, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 28, 2003
[Cloudberry: an important source of ellagic acid, an anti-oxidant]Barbara Thiem, Viktor Berge
European Urology|December 21, 2006
Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waitingViktor Berge, Trevor Thompson, Donald Blackman
Scandinavian Journal of Urology and Nephrology|May 1, 2007
Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waitingViktor Berge, Trevor Thompson, Donald Blackman
Scandinavian Journal of Urology and Nephrology|March 31, 2010
A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early resultsViktor Berge, Eduard Baco, Steinar Johan Karlsen
British Journal of Cancer|November 23, 2021
Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patientsManuel Ramirez-Garrastacho, Viktor Berge, Aija Linē, et al.
Neurourology and Urodynamics|April 12, 2002
Comparative study of pressure-flow parametersLars M Eri, Nicolai Wessel, Ole Tysland, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2016
Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validationLing Wang, Tore Skotland, Viktor Berge, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 21, 2011
Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancerViktor Berge, Eduard Baco, Alv A Dahl, et al.
European Urology Open Science|August 2, 2021
Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy RegimensKirsti Aas, Viktor Berge, Tor Åge Myklebust, et al.
Molecular Cancer|May 10, 2011
Regulation of PBX3 expression by androgen and Let-7d in prostate cancerHåkon Ramberg, Ayham Alshbib, Viktor Berge, et al.
Pageof 6